BN Business News
Add your company to Business Communicator →

Labour market · 17/11/20261 min read

Gene2Cure Foundation and Viralgen collaborate to advance a portfolio of gene therapy programs for rare and ultra-rare genetic conditions

EDITORIAL ILLUSTRATIONLMLabour marketBN
Illustration generated by Business News; it is not a source photograph.

Summary

Collaboration brings together Gene2Cure's portfolio development capabilities and Viralgen's proprietary Aava™ platform to support the efficient progression of programs for rare and ultra-rare genetic conditions toward the clinic. DONOSTIA / SAN SEBASTIÁN, Spain, Nov. 17, 2026 /PRNewswire/...

Original source language: PR Newswire UK — News ReleasesOpen original release →

Explore insights

Business insights →